NCT01784692 is a NA clinical trial of Immulina in Elderly Immune Senescence, sponsored by University of Mississippi Medical Center.

Who is sponsoring NCT01784692?

NCT01784692 is sponsored by University of Mississippi Medical Center.

What drugs are being tested in NCT01784692?

Interventions in NCT01784692: Immulina.

What condition does NCT01784692 study?

NCT01784692 studies Elderly Immune Senescence.

Is NCT01784692 still recruiting?

NCT01784692 is currently completed. Last updated 24 May 2016.

Last reviewed 2016-05-24 · How we verify

NCT01784692

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Study to Evaluate Immunopotentiating Effects of Immulina in Elderly Individuals

Completed NA Last updated 24 May 2016

What this trial tests

NA trial testing Immulina in Elderly Immune Senescence in 21 participants. Completed in 1 September 2014.

Timeline

1 April 2013

Primary endpoint
1 September 2014

1 September 2014

Quick facts

Lead sponsor	University of Mississippi Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	supportive care
Enrollment	21
Start date	1 April 2013
Primary completion	1 September 2014
Estimated completion	1 September 2014
Sites	1 location across United States

Drugs / interventions tested

Immulina — full drug profile →

Conditions studied

Elderly Immune Senescence — all drugs for Elderly Immune Senescence →

Sponsor

University of Mississippi Medical Center

Who can join

60 and older, any sex, with Elderly Immune Senescence. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Interferon gamma (IFNg)
Time frame: 8 weeks
Increase in IFNg from baseline to 8 weeks

Sponsor's own description

This will be a small study aimed at determining the effects of oral Immulina consumption on the immune system in elderly individuals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Immulina

Trials testing the same drug.

NCT05556967 — Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans · Phase 3 · completed

Other University of Mississippi Medical Center trials

Trials by the same sponsor.

NCT07431619 — A Web-Based Text Messaging for Tobacco Cessation in Rural Mississippi · NA · not yet recruiting
NCT07461662 — Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination · NA · not yet recruiting
NCT06216925 — Teen Mom Study: A Confirmatory Pragmatic Cluster RCT · NA · not yet recruiting
NCT06973642 — Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation · NA · recruiting
NCT07071064 — Mississippi Community Engagement Alliance (MS CEAL): Fostering Community Solutions · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01784692 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Mississippi Medical Center
Last refreshed: 24 May 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01784692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing